PPIs sometimes highly variable even in fasted state [Design Issues]

posted by DavidManteigas – Portugal, 2017-02-27 17:08 (2909 d 17:23 ago) – Posting: # 17114
Views: 6,327

Dear all,

Sometimes FDA ask for both fed and fast studies for products for which the SmPC states that no interaction with food occur. In those cases, would it be acceptable to use different designs for each study? Even when the variability in the fed study was preivously found to be higher in pilot studies, for example?

Never happened to me. I'm asking just for curiosity, since from my experience fed studies generally have higher variability than fast studies even when no food effect is expected.

Regards

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
72 visitors (0 registered, 72 guests [including 8 identified bots]).
Forum time: 10:31 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5